Development and application of receptor-modified T lymphocytes for adoptive immunotherapy.
about
IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytesTargeting tumours with genetically enhanced T lymphocytes.Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade.Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.Antigen-specific targeting of CD8+ T cells with receptor-modified T lymphocytes.Induction of tolerance and immunity by redirected B cell-specific cytolytic T lymphocytes.
P2860
Development and application of receptor-modified T lymphocytes for adoptive immunotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development and application of ...... es for adoptive immunotherapy.
@ast
Development and application of ...... es for adoptive immunotherapy.
@en
Development and application of ...... es for adoptive immunotherapy.
@nl
type
label
Development and application of ...... es for adoptive immunotherapy.
@ast
Development and application of ...... es for adoptive immunotherapy.
@en
Development and application of ...... es for adoptive immunotherapy.
@nl
prefLabel
Development and application of ...... es for adoptive immunotherapy.
@ast
Development and application of ...... es for adoptive immunotherapy.
@en
Development and application of ...... es for adoptive immunotherapy.
@nl
P356
P1476
Development and application of receptor-modified T lymphocytes for adoptive immunotherapy
@en
P2093
P356
10.1053/TMRV.2001.19949
P577
2001-01-01T00:00:00Z